This page shows the latest MDR news and features for those working in and with pharma, biotech and healthcare.
One company working in this area – Adaptive Phage Therapeutics – has just won FDA approval to start human testing of personalised bacteriophage therapeutics for serious MDR infections. ... strain. Arms of the study will also focus on specific bacteria
An independent UK review estimated that by 2050 MDR infections could claim 10 million lives a year and result in a cumulative loss from global output of $100trn. ... rates of multidrug resistant (MDR) strains, the need for new treatment options is
In particular, more needs to be done to bring forward new drugs for multidrug resistant (MDR) pathogens or ‘superbugs’ - there are currently 28 novel drugs for high-priority pathogens in phase
Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn
MDR infections are an increasing global threat," said Matteo Bassetti, chief of the infectious diseases Clinic at University of Udine in Italy. ... The availability of Zavicefta is a major step forward for physicians faced with the challenge of treating
ATM-AVI is in trials for life-threatening Gram-negative bacterial infections caused by multi-drug resistant (MDR) strains, while CXL has activity against MDR Gram-positive and Gram-negative pathogens.
More from news
Approximately 4 fully matching, plus 27 partially matching documents found.
Simply put, complying with MDR is another stressor for medtechs at an already challenging time, potentially affecting both top- and bottom-line growth. ... It's difficult to estimate just how great the costs associated with MDR implementation will
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
In this session, we heard from Bassil Akra, CEO of QUnique Group, who gave us a quick overview of the EU MDR. ... We’re pleased to hear that not only the pharma industry will benefit from the EU MDR, but there will be positive changes for patients too.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Valid Insight is an award-winning pharmaceutical global market access consultancy....